• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫纤维瘤的生物力学和胶原异质性的证据。

Evidence of biomechanical and collagen heterogeneity in uterine fibroids.

机构信息

Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina, United States of America.

Department of Pathology, Duke University School of Medicine, Durham, North Carolina, United States of America.

出版信息

PLoS One. 2019 Apr 29;14(4):e0215646. doi: 10.1371/journal.pone.0215646. eCollection 2019.

DOI:10.1371/journal.pone.0215646
PMID:31034494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6488189/
Abstract

OBJECTIVE

Uterine fibroids (leiomyomas) are common benign tumors of the myometrium but their molecular pathobiology remains elusive. These stiff and often large tumors contain abundant extracellular matrix (ECM), including large amounts of collagen, and can lead to significant morbidities. After observing structural multiformities of uterine fibroids, we aimed to explore this heterogeneity by focusing on collagen and tissue stiffness.

METHODS

For 19 fibroids, ranging in size from 3 to 11 centimeters, from eight women we documented gross appearance and evaluated collagen content by Masson trichrome staining. Collagen types were determined in additional samples by serial extraction and gel electrophoresis. Biomechanical stiffness was evaluated by rheometry.

RESULTS

Fibroid slices displayed different gross morphology and some fibroids had characteristics of two or more patterns: classical whorled (n = 8); nodular (n = 9); interweaving trabecular (n = 9); other (n = 1). All examined fibroids contained at least 37% collagen. Tested samples included type I, III, and V collagen of different proportions. Fibroid stiffness was not correlated with the overall collagen content (correlation coefficient 0.22). Neither stiffness nor collagen content was correlated with fibroid size. Stiffness among fibroids ranged from 3028 to 14180 Pa (CV 36.7%; p<0.001, one-way ANOVA). Stiffness within individual fibroids was also not uniform and variability ranged from CV 1.6 to 42.9%.

CONCLUSIONS

The observed heterogeneity in structure, collagen content, and stiffness highlights that fibroid regions differ in architectural status. These differences might be associated with variations in local pressure, biomechanical signaling, and altered growth. We conclude the design of all fibroid studies should account for such heterogeneity because samples from different regions have different characteristics. Our understanding of fibroid pathophysiology will greatly increase through the investigation of the complexity of the chemical and biochemical signaling in fibroid development, the correlation of collagen content and mechanical properties in uterine fibroids, and the mechanical forces involved in fibroid development as affected by the various components of the ECM.

摘要

目的

子宫肌瘤(平滑肌瘤)是子宫平滑肌的常见良性肿瘤,但它们的分子病理生物学仍不清楚。这些坚硬且通常较大的肿瘤含有丰富的细胞外基质(ECM),包括大量的胶原,可导致显著的病态。在观察到子宫肌瘤的结构多样性后,我们旨在通过关注胶原和组织硬度来探索这种异质性。

方法

我们记录了 8 名女性的 19 个大小从 3 厘米到 11 厘米不等的子宫肌瘤的大体外观,并通过 Masson 三色染色评估胶原含量。在其他样本中,通过连续提取和凝胶电泳确定胶原类型。通过流变仪评估生物力学硬度。

结果

肌瘤切片显示出不同的大体形态,有些肌瘤具有两种或更多种形态的特征:经典漩涡状(n=8);结节状(n=9);交织小梁状(n=9);其他(n=1)。所有检查的肌瘤均含有至少 37%的胶原。测试样本包括不同比例的 I 型、III 型和 V 型胶原。肌瘤硬度与总胶原含量无相关性(相关系数 0.22)。硬度和胶原含量均与肌瘤大小无关。肌瘤之间的硬度范围为 3028 至 14180 Pa(变异系数 36.7%;p<0.001,单因素方差分析)。单个肌瘤内的硬度也不均匀,变异性范围为 CV 1.6 至 42.9%。

结论

所观察到的结构、胶原含量和硬度的异质性突出表明,肌瘤区域在结构状态上存在差异。这些差异可能与局部压力、生物力学信号和生长改变有关。我们得出结论,所有子宫肌瘤研究的设计都应考虑到这种异质性,因为来自不同区域的样本具有不同的特征。通过研究子宫肌瘤发育过程中化学和生化信号的复杂性、子宫平滑肌瘤中胶原含量和机械性能的相关性以及 ECM 各种成分对肌瘤发育所涉及的机械力,我们对子宫肌瘤病理生理学的理解将大大增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/6488189/a7ba3af46fca/pone.0215646.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/6488189/83d0711f969b/pone.0215646.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/6488189/fa156541f363/pone.0215646.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/6488189/78e3b45dbf1a/pone.0215646.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/6488189/a7ba3af46fca/pone.0215646.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/6488189/83d0711f969b/pone.0215646.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/6488189/fa156541f363/pone.0215646.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/6488189/78e3b45dbf1a/pone.0215646.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf0/6488189/a7ba3af46fca/pone.0215646.g004.jpg

相似文献

1
Evidence of biomechanical and collagen heterogeneity in uterine fibroids.子宫纤维瘤的生物力学和胶原异质性的证据。
PLoS One. 2019 Apr 29;14(4):e0215646. doi: 10.1371/journal.pone.0215646. eCollection 2019.
2
Loss of stiffness in collagen-rich uterine fibroids after digestion with purified collagenase Clostridium histolyticum.用溶组织梭状芽孢杆菌纯化胶原酶消化富含胶原蛋白的子宫肌瘤后,其硬度丧失。
Am J Obstet Gynecol. 2016 Nov;215(5):596.e1-596.e8. doi: 10.1016/j.ajog.2016.05.006. Epub 2016 May 10.
3
Uterine fibroids: correlations between MRI appearance and stiffness via magnetic resonance elastography.子宫肌瘤:磁共振弹性成像显示的外观与硬度之间的相关性。
Abdom Radiol (NY). 2018 Jun;43(6):1456-1463. doi: 10.1007/s00261-017-1314-1.
4
Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids.细胞外基质和 Hippo 信号通路作为抗纤维化合物治疗子宫肌瘤的靶点。
Clin Transl Med. 2021 Jul;11(7):e475. doi: 10.1002/ctm2.475.
5
Injectable Clostridium histolyticum collagenase as a potential treatment for uterine fibroids.可注射性溶组织梭菌胶原酶作为一种治疗子宫肌瘤的潜在方法。
Reprod Sci. 2014 Dec;21(12):1452-9. doi: 10.1177/1933719114553449. Epub 2014 Oct 20.
6
A Phase I Clinical Trial to Assess Safety and Tolerability of Injectable Collagenase in Women with Symptomatic Uterine Fibroids.一项评估注射用胶原酶治疗有症状子宫肌瘤女性的安全性和耐受性的 I 期临床试验。
Reprod Sci. 2021 Sep;28(9):2699-2709. doi: 10.1007/s43032-021-00573-8. Epub 2021 Apr 29.
7
Uterine perfusion model for analyzing barriers to transport in fibroids.用于分析纤维瘤中转运障碍的子宫灌注模型。
J Control Release. 2015 Sep 28;214:85-93. doi: 10.1016/j.jconrel.2015.07.006. Epub 2015 Jul 13.
8
The management of uterine leiomyomas.子宫平滑肌瘤的管理
J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8.
9
MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.miRNA 21a-5p 的过表达影响了子宫肌瘤细胞外基质形成的介质。
Reprod Biol Endocrinol. 2018 May 11;16(1):46. doi: 10.1186/s12958-018-0364-8.
10
The management of uterine fibroids in women with otherwise unexplained infertility.患有不明原因不孕症的女性子宫肌瘤的管理。
J Obstet Gynaecol Can. 2015 Mar;37(3):277-285. doi: 10.1016/S1701-2163(15)30318-2.

引用本文的文献

1
The stem bark decoction of Myrianthus arboreus P. Beauv. (Cecropiaceae) shows anti-uterine leiomyoma effects in Wistar rat.乔木桑科植物多蕊桑(Myrianthus arboreus P. Beauv.)的茎皮煎剂对Wistar大鼠显示出抗子宫肌瘤的作用。
Reprod Fertil. 2025 Jul 26;6(3). doi: 10.1530/RAF-25-0037. Print 2025 Jul 1.
2
The influence of uterine leiomyomatosis on the onset of psoriasis: a nationwide population-based study of 2.5 million Korean females.子宫平滑肌瘤病对银屑病发病的影响:一项基于韩国250万女性人群的全国性研究。
BMC Womens Health. 2025 Feb 5;25(1):50. doi: 10.1186/s12905-024-03529-7.
3
Evaluation of the In Vivo Efficacy of the JAK Inhibitor AZD1480 in Uterine Leiomyomas Using a Patient-derived Xenograft Murine Model.

本文引用的文献

1
Proteomic Characterization of the Extracellular Matrix of Human Uterine Fibroids.人子宫肌瘤细胞外基质的蛋白质组学特征分析。
Endocrinology. 2018 Jul 1;159(7):2656-2669. doi: 10.1210/en.2018-00151.
2
Proteomic Profiling of Human Uterine Fibroids Reveals Upregulation of the Extracellular Matrix Protein Periostin.人类子宫肌瘤的蛋白质组分析揭示细胞外基质蛋白骨膜蛋白的上调。
Endocrinology. 2018 Feb 1;159(2):1106-1118. doi: 10.1210/en.2017-03018.
3
Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
使用患者来源的异种移植小鼠模型评估JAK抑制剂AZD1480在子宫平滑肌瘤中的体内疗效。
Reprod Sci. 2025 Feb;32(2):417-427. doi: 10.1007/s43032-024-01775-6. Epub 2024 Dec 29.
4
Racial disparity in uterine leiomyoma: new insights of genetic and environmental burden in myometrial cells.子宫肌瘤的种族差异:子宫平滑肌细胞中遗传和环境负担的新见解。
Mol Hum Reprod. 2024 Feb 29;30(3). doi: 10.1093/molehr/gaae004.
5
Material properties of nonpregnant and pregnant human uterine layers.非妊娠和妊娠人子宫层的材料性能。
J Mech Behav Biomed Mater. 2024 Mar;151:106348. doi: 10.1016/j.jmbbm.2023.106348. Epub 2023 Dec 28.
6
Regulation of oxytocin-induced calcium transients and gene expression in engineered myometrial tissues by tissue architecture and matrix rigidity.组织结构和基质硬度对工程化子宫肌层组织中催产素诱导的钙瞬变和基因表达的调节作用
Curr Res Physiol. 2023 Sep 21;6:100108. doi: 10.1016/j.crphys.2023.100108. eCollection 2023.
7
Upregulated TIMP1 facilitates and coordinates myometrial contraction by decreasing collagens and cell adhesive capacity during human labor.TIMP1 的上调通过减少胶原和细胞黏附能力促进和协调人分娩过程中的子宫收缩。
Mol Hum Reprod. 2023 Sep 30;29(10). doi: 10.1093/molehr/gaad034.
8
Prevention of Uterine Fibroids: molecular mechanisms and potential clinical application.子宫肌瘤的预防:分子机制与潜在临床应用
J Endometr Uterine Disord. 2023 Mar;1. doi: 10.1016/j.jeud.2023.100018. Epub 2023 Feb 15.
9
Update on the Role and Regulatory Mechanism of Extracellular Matrix in the Pathogenesis of Uterine Fibroids.关于细胞外基质在子宫肌瘤发病机制中的作用和调控机制的最新研究进展。
Int J Mol Sci. 2023 Mar 17;24(6):5778. doi: 10.3390/ijms24065778.
10
Uterine fibroids - Causes, impact, treatment, and lens to the African perspective.子宫肌瘤——病因、影响、治疗以及非洲视角的解读
Front Pharmacol. 2023 Jan 10;13:1045783. doi: 10.3389/fphar.2022.1045783. eCollection 2022.
子宫平滑肌瘤发病机制中的细胞外基质:未来治疗的潜在靶点。
Hum Reprod Update. 2018 Jan 1;24(1):59-85. doi: 10.1093/humupd/dmx032.
4
Overhydroxylation of Lysine of Collagen Increases Uterine Fibroids Proliferation: Roles of Lysyl Hydroxylases, Lysyl Oxidases, and Matrix Metalloproteinases.胶原赖氨酸过度羟化可促进子宫肌瘤增殖:赖氨酰羟化酶、赖氨酰氧化酶和基质金属蛋白酶的作用。
Biomed Res Int. 2017;2017:5316845. doi: 10.1155/2017/5316845. Epub 2017 Sep 10.
5
Global metabolomic profiling of uterine leiomyomas.子宫平滑肌瘤的全球代谢组学分析
Br J Cancer. 2017 Dec 5;117(12):1855-1864. doi: 10.1038/bjc.2017.361. Epub 2017 Oct 26.
6
Regulation of genome organization and gene expression by nuclear mechanotransduction.核机械转导调控基因组组织和基因表达。
Nat Rev Mol Cell Biol. 2017 Dec;18(12):717-727. doi: 10.1038/nrm.2017.101. Epub 2017 Oct 18.
7
Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.多种临床特征可将 MED12 突变阳性和阴性的子宫平滑肌瘤区分开来。
Sci Rep. 2017 Apr 21;7(1):1015. doi: 10.1038/s41598-017-01199-0.
8
Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.通过全外显子组测序和全基因组芯片分析子宫平滑肌瘤高度异质性的基因组格局
Fertil Steril. 2017 Feb;107(2):457-466.e9. doi: 10.1016/j.fertnstert.2016.10.035. Epub 2016 Nov 23.
9
Differences in the cellular composition of small versus large uterine fibroids.小子宫肌瘤与大子宫肌瘤细胞组成的差异。
Reproduction. 2016 Nov;152(5):467-80. doi: 10.1530/REP-16-0216. Epub 2016 Aug 15.
10
Uterine fibroids.子宫肌瘤。
Nat Rev Dis Primers. 2016 Jun 23;2:16043. doi: 10.1038/nrdp.2016.43.